Pharmaceutical Executive September 24, 2025
Mike Hollan

Ryan Quigley, CEO of Inizio, details the current usage of AI and other advanced technologies.

Pharmaceutical Executive: How was the transition from COO to CEO?
Ryan Quigley: The transition has been very smooth. I’ve worked at Inizio for the last four-to-five years. Our former CEO will continue as part of the board. We’ve been working on the transition for a period of time and we’re confident that it’s moving in the right direction.

I don’t know if it’s always the case, it’s been great that we’ve been able to work together. He’s one of the founders and helped build out the company and I was part of the journey with him. It’s been very useful that he’s staying on. It takes...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: AI (Artificial Intelligence), Biotechnology, Interview / Q&A, Pharma, Pharma / Biotech, Technology, Trends
Infographic: ECRI’s Top 10 Tech Hazards of 2026
Doctors Increasingly See AI Scribes in a Positive Light. But Hiccups Persist.
The Download: OpenAI’s plans for science, and chatbot age verification
AI Personas Of Synthetic Clients Spurs Systematic Uplift Of Mental Health Therapeutic Skills
Models that improve on their own are AI's next big thing

Share Article